Table 1.
Group(n) | Primary (%) | Recurrence (%) | |||||||
---|---|---|---|---|---|---|---|---|---|
0+ | 1+ | 2+ | 3+ | 0+ | 1+ | 2+ | 3+ | P a | |
No adjuvant therapy n = 8 | 1 | 0 | 1 | 6 | 1 | 1 | 2 | 4 | 0.317 |
Adjuvant therapy n = 15 | 1 | 1 | 0 | 14 | 5 | 3 | 5 | 3 | 0.003 |
Chemo-radiotherapy n = 12 | 1 | 1 | 0 | 10 | 5 | 2 | 3 | 2 | |
Radiotherapy n = 3 | 0 | 0 | 0 | 3 | 0 | 1 | 1 | 1 | |
Chemotherapy n = 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
aWilcoxon rank sum test was used to analyze the change of SOX2 expression between paired primary and recurrent samples